No “Co” for CD28 in NK cells: CD28-harnessed natural killer cells mediate APC lysis independently of T-cell receptor presence or engagement
The Journal of Immunology · 02.11.2026 · 215 (11)
DOI: 10.1093/jimmun/vkag313 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 13.11.2026. Verfasst von Els P van Hees und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: CD28 Antigens, Killer Cells, Natural, Receptors, Antigen, T-Cell, Antigen-Presenting Cells. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Cancer Society.
Abstract (Originalsprache)
Recently, primary natural killer (NK) cells have been engineered to express a transgenic T-cell receptor (NK:TCR), enabling recognition of intracellular and extracellular tumor antigens via HLA-restricted presentation. While this strategy broadens antigen specificity, NK cells lack canonical co-stimulatory receptors required for optimal T-cell activation. In T cells, CD28 engagement with CD80 and CD86 provides the essential “signal 2” that drives proliferation, differentiation, and cytokine production. We therefore examined whether expression of wild-type CD28 could facilitate co-stimulatory function to NK:TCR cells. Wild-type CD28 was introduced into NK-92 NFAT reporter cells and primary NK cells to assess its activity in the absence of TCR signaling. In parallel, CD28 was co-expressed with either relevant or irrelevant TCRs to evaluate its role in TCR-mediated responses. Our results show that CD28 signaling in NK cells differs from its role in T cells. CD28 functioned as a primary activating receptor, inducing activation upon interaction with CD80 or CD86 even in the absence of TCR engagement, resulting in the lysis of CD80- and/or CD86-positive cells, including antigen-presenting cells. This effect required the intracellular signaling domain of CD28. Blocking experiments demonstrated that both CD80 and CD86 are sufficient to drive activation, with no evidence for additional ligands. Notably, the presence of an irrelevant TCR did not restrain CD28-driven activation. These findings reveal fundamental differences in CD28-mediated signaling between NK and T cells and highlight a potential safety concern for NK-based therapies, as full-length CD28 expression may promote TCR-independent activation and cytotoxicity toward CD80/CD86-expressing cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Els P van Hees, Ramon Arens
Förderung
- Dutch Cancer Society
Zitieren
APA
van Hees, E. P., Starink, L. I. W., Poortvliet, T., Hagedoorn, R. S., Remst, D. F. G., Arens, R., & Heemskerk, M. H. M. (2026). No “Co” for CD28 in NK cells: CD28-harnessed natural killer cells mediate APC lysis independently of T-cell receptor presence or engagement. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag313
Vancouver
van Hees EP, Starink LIW, Poortvliet T, Hagedoorn RS, Remst DFG, Arens R, et al. No “Co” for CD28 in NK cells: CD28-harnessed natural killer cells mediate APC lysis independently of T-cell receptor presence or engagement. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag313
BibTeX
@article{vanHees2026,
author = {van Hees, Els P and Starink, Lineke I W and Poortvliet, Teuntje and Hagedoorn, Renate S and Remst, Dennis F G and Arens, Ramon and Heemskerk, Mirjam H M},
title = {No “Co” for CD28 in NK cells: CD28-harnessed natural killer cells mediate APC lysis independently of T-cell receptor presence or engagement},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {11},
doi = {10.1093/jimmun/vkag313}
}
EUVIMED